According to a new study published in Nature Communications, researchers at the Department of Laboratory Medicine, Karolinska ...
The program has recently become controversial as a number of high-profile advanced approvals were granted only for the drugs ...
A groundbreaking phase one clinical trial explored a novel cell-based immunotherapy for breast cancer. The study focuses on a new treatment approach that aims to harness the body's immune system to ...
Researchers have developed a three-step plan to support those burdened by the intense fear of cancer returning. This plan offers a consistent, streamlined approach to managing recurrence anxiety, ...
The University of Cincinnati’s Ishita Basu, PhD, has been awarded an $810,000 United States Department of Defense grant to ...
New research challenges the notion that tumors operate as 'two-speed' entities. Scientists from the University of Cologne and ...
In a comprehensive Genomic Press Interview, distinguished psychiatrist Professor Peter Falkai suggests promising new ...
ShiraTronics has commenced the pivotal RELIEV-CM2 CLINICAL Study of its implantable neuromodulation therapy, designed for ...
Tribe Clinical Research in Greenville has announced the launch of a new trial for a drug centered around Alzheimer's ...
WW International, Inc. WW stock has shown a remarkable performance in the past three months, outpacing the S&P 500 and the ...
At Scripps Research, a research team led by Associate Professor Anne Hanneken, in the Department of Molecular Medicine, will ...